Commentary · 21 Feb 2026
Conference abstractPublished 20 Oct 2014
Novel in silico-designed anti-cancer compounds: From in vitro exploration to potential clinical considerations
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The concept behind these novel in silico-designed anti-cancer compounds encompasses harnessing the well described anti-mitotic effects of 2-methoxyestradiol with modifications to increase bioavailability, as well as preferential tumour localization via carbonic anhydrase IX binding. Spectrophotometric dose analysis revealed that these novel compounds are cytotoxic at nanomolar concentrations in a number of neoplastic cell types, a property retained in a PgP-overexpressing multi-drug resistant cell line. Microscopy techniques including live imaging of tubulin dynamics confirmed the induction of apoptosis and autophagy due to alternation of spindle dynamics. Molecular pathways and intracellular responses were assessed via multiple techniques including Western blotting and flow cytometry. Chick chorioallantoic membrane assays revealed a significant reduction in primary tumour size and a decreased number of distant metastasis. Ex vivo effects on human blood, as well as potential platelet interference were examined both microscopically and via flow cytometry. In bridging the gap towards clinical applications, acute mouse toxicity and metabolism studies were performed. Potential effects on haematopoietic stem cells were investigated; the results of which indicated that the compounds are not toxic at the IC50 concentrations established for cancer cells. Additionally, after drug exposure, stem cells retained their differentiating capacity. Potential use of the compounds within a combined treatment regimen was investigated; both with established chemotherepeutic drugs in spectrophotometric matrices, and in radiosensitization studies. Further studies will encompass mouse tumour models, as well as to elucidated whether the conceptual preferential tumour localization is achieved in vivo.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Cancer Science & Therapy.
Perspective · 21 Feb 2026
Finding Potential Passerini Adducts for Anticancer Drug Development
Perspective · 21 Feb 2026
Head and Neck Cutaneous Squamous Cell Carcinoma with Perineural Invasion
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCancer Science & Therapy
- SubjectOncology & Cancer
- BylineArticles whose byline prints “A E Theron”
- BylineArticles whose byline prints “L Lafanechère”
- BylineArticles whose byline prints “M S Pepper”
- BylineArticles whose byline prints “R Prudent”
- BylineArticles whose byline prints “J Viallet”
- BylineArticles whose byline prints “C Jackson”
- BylineArticles whose byline prints “C du Rant”
- BylineArticles whose byline prints “A M Joubert”
